The CONTRIBUTE Study is looking at whether a study medication (a new medication that is under development) is safe and effective in people with ulcerative colitis that is not well controlled using their current medication. You might be able to participate if you: are between 18 and 75 years of age have been diagnosed with mild of moderate ulcerative colitis are having ulcerative colitis symptoms even though you have been taking tables such as sulfasalazine (Azulfidine), mesalamine (Pentasa, Rowasa, Asacol, Lialda) or olsalazine (Dipentum) for at least 6 weeks. The CONTRIBUTE Study will last for approximately 12 weeks and will require six visits to the study center. If you are eligible to participate in the CONTRIBUTE Study, you will receive study-related medication and health assessments at no cost and may be reimbursed for transportation costs. Think this Study may be right for you? Email your contact information... or Call 228.872.7612 and ask for Luan **You cannot make appointments with this form. Please leave your contact information and we will get back to you soon** Send Welcome to DHC First Visit? Medical Team Office Locations Clinical Trials Illnesses Procedures Privacy Notice Copyright 2020 Digestive Health Center, PA.

Clinical Trials & Research Studies "This treatment could be just right for you." -Marshea, FNP-C Digestive Health Center participates in clinical trials & investigations in digestive diseases and gastrointestinal disorders. We are one of the few study sites on the Gulf Coast of Mississippi. Digestive Health Center comprises physicians, registered nurses, and clinical research coordinators who have years of experience in safely performing clinical trials. We conduct our clinical research in strict accordance with the regulations of the Food and Drug Administration and a study specific Institutional Review Board. ﻿Research studies offer our patients an opportunity to take advantage of exciting new medications and other treatments for variety of conditions. We select trials based on their perceived potential merit to our patients. Participation in these trials is voluntary. Deciding to take part in a research study is an important decision. A crucial component of this decision involves a discussion with a Digestive Health Center associate and a review of a document detailing the current treatments available, rationale for why the new therapy is being considered, the perceived potential risks and benefits of participation, the responsibilities of the treating physician, and the patient's rights. Pharmaceutical companies sponsor most of our research studies. Depending on the particular trial, the pharmaceutical companies will often cover the cost of medications, office visits, and laboratory studies for patients. It is important for patients to understand that these companies will also reimburse Digestive Health Center for study visits. Learn about our new trial... Call 228.872.7612 For more info on our trials Welcome to DHC First Visit? Medical Team Office Locations Clinical Trials Illnesses Procedures Privacy Notice Copyright 2020 Digestive Health Center, PA.